↓ Skip to main content

Dove Medical Press

Risks vs benefits of glatiramer acetate: a changing perspective as new therapies emerge for multiple sclerosis

Overview of attention for article published in Therapeutics and Clinical Risk Management, April 2010
Altmetric Badge

Mentioned by

wikipedia
3 Wikipedia pages

Citations

dimensions_citation
15 Dimensions

Readers on

mendeley
54 Mendeley
Title
Risks vs benefits of glatiramer acetate: a changing perspective as new therapies emerge for multiple sclerosis
Published in
Therapeutics and Clinical Risk Management, April 2010
DOI 10.2147/tcrm.s6743
Pubmed ID
Authors

Kenneth P Johnson

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 54 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 2%
Spain 1 2%
Portugal 1 2%
Unknown 51 94%

Demographic breakdown

Readers by professional status Count As %
Researcher 12 22%
Student > Ph. D. Student 8 15%
Student > Bachelor 6 11%
Student > Doctoral Student 4 7%
Other 4 7%
Other 9 17%
Unknown 11 20%
Readers by discipline Count As %
Medicine and Dentistry 25 46%
Agricultural and Biological Sciences 6 11%
Neuroscience 3 6%
Biochemistry, Genetics and Molecular Biology 2 4%
Immunology and Microbiology 1 2%
Other 3 6%
Unknown 14 26%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 October 2010.
All research outputs
#8,535,684
of 25,374,917 outputs
Outputs from Therapeutics and Clinical Risk Management
#461
of 1,323 outputs
Outputs of similar age
#38,291
of 103,518 outputs
Outputs of similar age from Therapeutics and Clinical Risk Management
#3
of 4 outputs
Altmetric has tracked 25,374,917 research outputs across all sources so far. This one is in the 43rd percentile – i.e., 43% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,323 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.6. This one has gotten more attention than average, scoring higher than 55% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 103,518 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 21st percentile – i.e., 21% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 4 others from the same source and published within six weeks on either side of this one.